Step-up fecal microbiota transplantation (FMT) strategy

Gut Microbes

Volumn 7, Issue 4, 2016, Pages 323-328

  Cui, Bota ^a,b   Li, Pan ^a,b   Xu, Lijuan ^a,b   Peng, Zhaoyuan ^a,b   Xiang, Jie ^a,b   He, Zhi ^a,b   Zhang, Ting ^a,b   Ji, Guozhong ^a,b   Nie, Yongzhan ^c   Wu, Kaichun ^c   Fan, Daiming ^c   Zhang, Faming ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dysbiosis; Inflammatory bowel disease; Step up fecal microbiota transplantation; Steroids; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; ENEMA; MESALAZINE; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR;

ABDOMINAL PAIN; ARTICLE; BLOATING; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DIARRHEA; ENTERIC FEEDING; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEVER; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; TRANSENDOSCOPIC ENTERAL TUBING; ULCERATIVE COLITIS; BACTERIUM; EVALUATION STUDY; FECES; GASTROINTESTINAL TRACT; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFLAMMATORY BOWEL DISEASES; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; STANDARDS;

BACTERIA; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84962355471     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1151608     Document Type: Article

References (46)

1. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015; 12:205-17; PMID:25732745; http://dx.doi.org/10.1038/nrgastro.2015.34
2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010; 28:573-621; PMID:20192811; http://dx.doi.org/10.1146/annurevimmunol-030409-101225
3. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60:571-607; PMID:21464096; http://dx.doi.org/10.1136/gut.2010.224154
4. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012; 107:1755; PMID:23160295; http://dx.doi.org/10.1038/ajg.2012.251
5. Kao D, Hotte N, Gillevet P, Madsen K. Fecal microbiota transplantation inducing remission in Crohn’s colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 2014; 48:625-8; PMID:24667590; http://dx.doi.org/10.1097/MCG.0000000000000131
6. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108:500-8; PMID:23511459; http://dx.doi.org/10.1038/ajg.2013.59
7. Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med 2015; 13:298; PMID:26363929; http://dx.doi.org/10.1186/s12967-015-0646-2
8. Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn’s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015; 30:51-8; PMID:25168749; http://dx.doi.org/10.1111/jgh.12727
9. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015; 149:102-9 e6; PMID:25857665; http://dx.doi.org/10.1053/j.gastro.2015.04.001
10. Gordon H, Harbord M. A patient with severe Crohn’s colitis responds to Faecal Microbiota Transplantation. J Crohns Colitis 2014; 8:256-7; PMID:24239403; http://dx.doi.org/10.1016/j.crohns.2013.10.007
11. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010; 28:623-67; PMID:20192812; http://dx.doi.org/10.1146/annurev-immunol-030409-101330
12. Yurist-Doutsch S, Arrieta MC, Vogt SL, Finlay BB. Gastrointestinal microbiota-mediated control of enteric pathogens. Annu Rev Genet 2014; 48:361-82; PMID:25251855; http://dx.doi.org/10.1146/annurevgenet-120213-092421
13. Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013; 13:321-35; PMID:23618829; http://dx.doi.org/10.1038/nri3430
14. Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9:599-608; PMID:22907164; http://dx.doi.org/10.1038/nrgastro.2012.152
15. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-30; PMID:22972295; http://dx.doi.org/10.1038/nature11550
16. Dogra S, Sakwinska O, Soh SE, Ngom-Bru C, Bruck WM, Berger B, Brussow H, Karnani N, Lee YS, Yap F, et al. Rate of establishing the gut microbiota in infancy has consequences for future health. Gut Microbes 2015; 6:321-5; PMID:26516657; http://dx.doi.org/10.1080/19490976.2015.1078051
17. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013; 108:1620-30; PMID:24060759; http://dx.doi.org/10.1038/ajg.2013.257
18. Dai YX, Shi CB, Cui BT, Wang M, Ji GZ, Zhang FM. Fecal microbiota transplantation and prednisone for severe eosinophilic gastroenteritis. World J Gastroenterol 2014; 20:16368-71; PMID:25473198
19. Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease. World J Gastroenterol 2013; 19:7213-6; PMID:24222969; http://dx.doi.org/10.3748/wjg.v19.i41.7213
20. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013; 29:79-84; PMID:23041678; http://dx.doi.org/10.1097/MOG.0b013e32835a4b3e
21. Borody TJ, Brandt LJ, Paramsothy S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol 2014; 30:97-105; PMID:24257037; http://dx.doi.org/10.1097/MOG.0000000000000027
22. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15:337; PMID:23852569; http://dx.doi.org/10.1007/s11894-013-0337-1
23. Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointestinal Endoscopy 2013; 78:240-9; PMID:23642791; http://dx.doi.org/10.1016/j.gie.2013.03.1329
24. Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015; 149:223-37; PMID:25982290; http://dx.doi.org/10.1053/j.gastro.2015.05.008
25. Cui B, Li P, Xu L, Peng Z, Zhao Y, Wang H, He Z, Zhang T, Ji G, Wu K, et al. Fecal microbiota transplantation is an effective rescue therapy for refractory inflammatory bowel disease. Inflamm Cell Signal 2015; 2:e757.
26. Allegretti JR, Korzenik JR, Hamilton MJ. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection. J Vis Exp 2014; PMID:25549239
27. Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A, Lowenberg M, van den Brink GR, Mathus-Vliegen EM, de Vos WM, et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology 2015; 149:110-8.e4; PMID:25836986; http://dx.doi.org/10.1053/j.gastro.2015.03.045
28. Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, Deutschmann A, Wenzl HH, Petritsch W, Krejs GJ, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013; 19:2155-65; PMID:23899544; http://dx.doi.org/10.1097/MIB.0b013e31829ea325
29. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. J Crohns Colitis 2014; 8:1569-81; PMID:25223604; http://dx.doi.org/10.1016/j.crohns.2014.08.006
30. Cui B, Xu F, Zhang F. Methodology, Not Concept of Fecal Microbiota Transplantation, Affects Clinical Findings. Gastroenterology 2016; 150:285-6; PMID:26616573; http://dx.doi.org/10.1053/j.gastro.2015.05.065
31. Paramsothy S, Borody TJ, Lin E, Finlayson S, Walsh AJ, Samuel D, van den Bogaerde J, Leong RW, Connor S, Ng W, et al. Donor Recruitment for Fecal Microbiota Transplantation. Inflamm Bowel Dis 2015; 21:1600-6; PMID:26070003; http://dx.doi.org/10.1097/MIB.0000000000000405
32. Vermeire S, Joossens M, Verbeke K, Wang J, Machiels K, Sabino J, Ferrante M, Van Assche G, Rutgeerts P, Raes J. Donor species richness determines fecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis 2015; PMID:26519463
33. Brandt LJ. Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013; 108:177-85; PMID:23318479; http://dx.doi.org/10.1038/ajg.2012.450
34. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-15; PMID:23323867; http://dx.doi.org/10.1056/NEJMoa1205037
35. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108:478-98; quiz 99; PMID:23439232; http://dx.doi.org/10.1038/ajg.2013.4
36. Lee CH, Steiner T, Petrof EO, Smieja M, Roscoe D, Nematallah A, Weese JS, Collins S, Moayyedi P, Crowther M, et al. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. JAMA 2016; 315:142-9; PMID:26757463; http://dx.doi.org/10.1001/jama.2015.18098
37. Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 2013; 62:1653-64; PMID:24104886; http://dx.doi.org/10.1136/gutjnl-2012-303955
38. Sartor R, Mazmanian S. Intestinal microbes in inflammatory bowel diseases. Am J Gastroenterol 2012; 1:15-21; http://dx.doi.org/10.1038/ajgsup.2012.4
39. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014; 312:1772-8; PMID:25322359; http://dx.doi.org/10.1001/jama.2014.13875
40. Postigo R, Kim JH. Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012; 40:643-8; PMID:22847629; http://dx.doi.org/10.1007/s15010-012-0307-9
41. Li Q, Wang C, Tang C, He Q, Zhao X, Li N, Li J. Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report. Crit Care 2015; 19:738; PMID:25881250
42. Mattila E, Uusitalo-Seppala R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppala M, Mattila PS, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142:490-6; PMID:22155369; http://dx.doi.org/10.1053/j.gastro.2011.11.037
43. Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, Li P, Huang G, Ji G, Nie Y, et al. Colonic transendoscopic enteral tubing: A novel delivering way for fecal microbiota transplantation. Endoscopy International Open 2016; In press
44. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37:42-7; PMID:12811208; http://dx.doi.org/10.1097/00004836-200307000-00012
45. Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, Aroniadis O, Barto A, Borody T, Giovanelli A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014; 109:1065-71; PMID:24890442; http://dx.doi.org/10.1038/ajg.2014.133
46. Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H, Jr., Cloney D, Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56:597-601; PMID:23542823; http://dx.doi.org/10.1097/MPG.0b013e318292fa0d